(Q48238011)

9 February 2018

title

Systemic antiphospholipid syndrome. (English)

1 reference

9 February 2018

1

Y Shoenfeld

1 reference

9 February 2018

1 January 2003

1 reference

9 February 2018

number of pages

2

1 reference

based on heuristic

inferred from page(s)

published in

Lupus

1 reference

9 February 2018

volume

12

1 reference

9 February 2018

issue

7

1 reference

9 February 2018

page(s)

497-498

1 reference

9 February 2018

Thrombosis, abortion, cerebral disease, and the lupus anticoagulant

cites work

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU396XX

Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU396XX

Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3)

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU396XX

The putative role of cytokines in the induction of primary anti-phospholipid syndrome in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU396XX

Immunization with anticardiolipin cofactor (beta-2-glycoprotein I) induces experimental antiphospholipid syndrome in naive mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU396XX

In vitro effect of anticardiolipin autoantibodies upon total and pulsatile placental hCG secretion during early pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU396XX

Prevention of fetal loss in experimental antiphospholipid syndrome by low-molecular-weight heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU396XX

The effect of aspirin on recurrent fetal loss in experimental antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU396XX

Prevention of fetal loss in experimental antiphospholipid syndrome by in vivo administration of recombinant interleukin-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU396XX

Effect of long-acting thromboxane receptor antagonist (BMS 180,291) on experimental antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU396XX

Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU396XX

Prevention of experimental antiphospholipid syndrome and endothelial cell activation by synthetic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU396XX

10.1191/0961203303LU396XX

21 January 2018

Identifiers

DOI

1 reference

9 February 2018

PubMed ID

12892386

1 reference

9 February 2018